Fig. 4From: Two-year assessment of the efficacy and safety of sitagliptin in elderly patients with type 2 diabetes: Post hoc analysis of the ASSET-K studyChanges in fasting plasma glucose over the 2-year observation period. ANOVA, analysis of variance; FPG, fasting plasma glucoseBack to article page